Specialized payload retention testing services for lipid nanoparticle encapsulation projects involving RNA, proteins, peptides, small molecules, hydrophilic cargos, hydrophobic cargos, and co-encapsulated payload systems.
High initial encapsulation efficiency does not always mean that a lipid nanoparticle formulation can retain its payload during purification, buffer exchange, dilution, storage, incubation, or downstream biological evaluation. Payload leakage may appear as rapid burst release, gradual diffusion, surface desorption, particle destabilization, RNA exposure, protein loss, small-molecule partitioning, or assay-dependent free payload interference. BOC Sciences provides payload retention testing for LNP encapsulation to help pharmaceutical and biotechnology researchers understand whether an LNP formulation keeps its cargo inside the particle or associated with the intended lipid phase under project-relevant conditions. Our service connects lipid nanoparticle encapsulation, free payload differentiation, particle characterization, stress-condition comparison, and retention-oriented formulation interpretation, enabling research teams to select LNP candidates with stronger formulation robustness and clearer analytical evidence.
Payload retention testing helps determine whether an LNP formulation can maintain its encapsulated or particle-associated cargo after preparation, purification, storage, dilution, reconstitution, handling, and assay-relevant exposure. BOC Sciences designs retention testing programs according to the testing purpose and use scenario, helping researchers evaluate initial encapsulation robustness, leakage risk, storage-related payload loss, freeze-thaw sensitivity, dilution stability, and release-associated retention behavior. Each test can be adapted for RNA, protein, peptide, small-molecule, hydrophilic, hydrophobic, or co-encapsulated payload systems.
Initial retention testing confirms how much payload remains encapsulated or particle-associated immediately after LNP preparation and purification. This is useful for comparing formulation processes, screening lipid compositions, and evaluating batch-to-batch consistency before further stability or functional studies.
Storage stability retention testing evaluates whether payload leakage, degradation, aggregation, or particle destabilization occurs over selected storage periods and temperature conditions. It helps research teams understand whether an LNP formulation maintains payload association during practical sample storage.
Retention monitoring during in vitro exposure tracks how much payload remains associated with LNPs under assay-relevant conditions. This testing helps distinguish unwanted premature leakage from controlled release behavior and supports interpretation of uptake, localization, or functional response data.
Freeze-thaw retention testing evaluates whether repeated freezing and thawing cause payload leakage, particle aggregation, lipid matrix disruption, or loss of sample recovery. This is especially important for LNP samples that may require frozen storage or temperature-variable handling.
Dilution or reconstitution can shift the equilibrium between LNPs, payload, buffer components, and surrounding media. This testing verifies whether payload remains retained after sample dilution, concentration adjustment, buffer addition, or reconstitution before downstream experimental use.
Purification and buffer exchange can remove free payload, but they may also strip weakly associated cargo from LNPs or destabilize particles. This testing compares cleanup workflows to determine whether payload loss is caused by poor encapsulation, separation stress, membrane adsorption, or buffer incompatibility.
Accurate payload retention testing depends on methods that can distinguish retained, encapsulated, surface-associated, and free payload fractions. BOC Sciences supports multiple separation and quantification methods for RNA, DNA, protein, peptide, fluorescent probe, and small-molecule LNP formulations. Method selection is based on payload chemistry, assay sensitivity, particle stability, and the testing purpose.
| Methodology | Technical Principle | Applicable Payload Types |
|---|---|---|
| Ultrafiltration / Centrifugal Separation + Quantitative Analysis | Free payload and LNP-associated payload are separated through membrane- or size-based workflows, then quantified using payload-specific assays. This method supports comparison of total payload, free payload, retained payload, and recovery after dilution, storage, buffer exchange, or freeze-thaw exposure. | Broadly applicable to many small molecules, nucleic acids, peptides, and soluble payloads when membrane compatibility and adsorption behavior are suitable. |
| Fluorescence Quenching Method / Dye Exclusion Assay | Membrane-impermeable dyes or quenchers are used to distinguish externally accessible fluorescent payload from payload protected inside LNPs. Signal comparison before and after particle disruption helps estimate encapsulated or retained fractions. | Fluorescently labeled nucleic acids, fluorescent probes, reporter payloads, and fluorescence-compatible model cargo systems. |
| RNase Protection Assay | RNase degrades free or externally accessible RNA, while RNA protected inside intact LNPs remains undigested. Quantification after particle disruption supports evaluation of protected RNA fraction, leakage, and RNA accessibility. | mRNA, siRNA, saRNA, circRNA, miRNA, ASO-related RNA systems, and other RNA payloads compatible with nuclease-protection analysis. |
| DNase Protection Assay | DNase digests free or externally exposed DNA payloads, while DNA retained inside intact LNPs remains protected. The method helps assess DNA encapsulation protection, retention after processing, and exposure changes after dilution or storage. | pDNA, ssDNA, dsDNA, DNA oligonucleotides, DNA fragments, and DNA-containing LNP formulations. |
| Gel Electrophoresis Mobility Analysis | Nucleic acid migration behavior is compared to determine whether payload remains complexed, encapsulated, released, or degraded. This method provides visual confirmation of free versus LNP-associated nucleic acid fractions. | RNA and DNA payloads, including siRNA, mRNA fragments, oligonucleotides, plasmid DNA, and other nucleic acid-based cargos. |
| SEC-HPLC / Field-Flow Fractionation Separation and Quantification | Size-based separation resolves LNP-associated payload from free payload, aggregates, or smaller soluble fractions. Quantitative integration or fraction analysis supports retention evaluation for complex formulations where simple membrane separation may be insufficient. | Macromolecular payloads, proteins, peptides, nucleic acids, protein complexes, large reporter cargos, and heterogeneous LNP systems. |
| Radiolabeled Payload Tracing | A labeled payload is tracked with high sensitivity to measure retention, leakage, or distribution between fractions under defined experimental conditions. This method is useful when payload concentration is very low or conventional detection is not sensitive enough. | Low-abundance payloads, trace-level small molecules, labeled nucleic acids, labeled peptides, and specialized model cargo systems. |
Move beyond initial encapsulation efficiency by testing leakage, free payload increase, particle change, and retained cargo under project-relevant handling and assay conditions.
BOC Sciences supports payload retention testing for a broad range of LNP encapsulation systems. Each testing plan is designed according to payload type, analytical detectability, expected leakage mechanism, and downstream research use. We help clients evaluate whether their formulation maintains cargo association after purification, dilution, storage, handling, and incubation, while also linking retention data to particle attributes and formulation variables.
| LNP Retention Testing System Type | Supported Payloads, Testing Focus & Retention Considerations | Request Information |
|---|---|---|
| Nucleic Acid LNP Retention Testing | Suitable for mRNA, siRNA, saRNA, circRNA, miRNA, ASO, pDNA fragments, and other nucleic acid payloads. Testing focuses on protected versus accessible nucleic acid, payload leakage after dilution or storage, nuclease-accessible fraction, particle-size change, and relationship between RNA retention and lipid composition. For nucleic acid projects, retention testing can be coordinated with nucleic acids encapsulation in LNPs when formulation and analytical development are both required. | Inquiry |
| Protein LNP Retention Testing | Designed for enzymes, recombinant proteins, protein antigens, antibody fragments, cytokines, growth factors, fluorescent proteins, and protein complexes. Testing evaluates free protein increase, surface-associated protein behavior, retained protein after purification, activity or signal retention when applicable, and aggregation-related particle changes. Projects may be connected with protein encapsulation in LNPs when payload-specific formulation screening is needed. | Inquiry |
| Peptide LNP Retention Testing | Supports linear peptides, cyclic peptides, cell-interacting peptides, peptide antigens, peptide-drug conjugate models, and charged peptide payloads. Testing focuses on peptide desorption, diffusion, adsorption to purification devices, free peptide interference, and retained peptide fraction after dilution or media exposure. For peptide-oriented development, retention testing can be paired with peptide encapsulation in LNPs. | Inquiry |
| Hydrophobic Payload Retention Testing | Applicable to lipid-partitioning small molecules, hydrophobic dyes, poorly soluble compounds, and model drug payloads. Testing evaluates whether the payload remains associated with the lipid matrix or partitions into protein-containing media, plastic surfaces, filters, or precipitated phases. Method design considers compound solubility, logP/logD, detection method, and lipid compatibility. | Inquiry |
| Hydrophilic Payload Retention Testing | Suitable for polar small molecules, charged compounds, hydrophilic dyes, peptide-like cargos, and aqueous-core-associated payloads. Testing focuses on diffusion-driven leakage, charge-assisted retention, buffer-dependent payload migration, and free payload increase after dilution, dialysis, or storage. Retention results can guide whether a formulation requires stronger lipid-payload interaction or revised encapsulation conditions. | Inquiry |
| Co-Encapsulated Payload Retention Testing | Designed for LNPs containing two or more payloads, such as RNA-small molecule, RNA-protein, peptide-small molecule, dual-RNA, or antigen-adjuvant model systems. Testing evaluates whether each payload is retained at the desired ratio after purification, dilution, storage, and incubation. The workflow can be aligned with co-encapsulation of multiple payloads in LNPs for formulation optimization. | Inquiry |
| Targeted or Surface-Modified LNP Retention Testing | Supports LNP systems containing targeting ligands, PEG-lipid anchors, peptide motifs, antibody fragments, or surface-functional components. Testing evaluates whether surface modification changes payload leakage, particle aggregation, free payload signal, or retention after media exposure. This is useful when targeting design and payload stability must be balanced in the same formulation. | Inquiry |
| Formulation Screening-Based Retention Testing | Used when several LNP candidates must be compared to select a more robust formulation. We evaluate retention across lipid compositions, lipid-to-payload ratios, flow conditions, PEG-lipid levels, purification methods, and buffer systems. Candidate ranking is based on retained payload percentage, free payload increase, particle size, PDI, zeta potential, and practical sample recovery. | Inquiry |
LNP retention problems often remain hidden when formulation decisions rely only on initial encapsulation efficiency. We help clients identify when, where, and why payload loss occurs.
✔ High Initial Loading but Rapid Payload Leakage
A formulation may look successful immediately after preparation but lose cargo after buffer exchange, dilution, or short-term storage. We compare total, free, and retained payload fractions across defined time points to reveal leakage that initial loading analysis may miss.
✔ Free Payload Interference in Cell-Based Readouts
Free RNA, protein, peptide, or small molecule can distort uptake, localization, fluorescence, activity, or response assays. We evaluate free payload increase after sample preparation and connect retention data with nanoparticle in vitro evaluation needs.
✔ Payload Loss During Purification
Dialysis, filtration, chromatography-related cleanup, or centrifugal concentration can remove free payload but may also strip weakly associated cargo from LNPs. We compare pre- and post-purification retention, recovery, and particle quality to select a gentler cleanup strategy.
✔ Particle Instability Linked to Payload Release
Payload leakage may coincide with particle growth, aggregation, PDI broadening, surface charge shift, or visible precipitation. We monitor particle attributes together with retention to determine whether cargo loss is driven by particle destabilization or payload-specific diffusion.
✔ Poor Retention After Storage or Freeze-Thaw
Storage conditions can change lipid packing, particle distribution, and payload accessibility. We evaluate retention after selected storage temperatures, freeze-thaw cycles, and handling conditions to identify formulation designs with better sample robustness.
✔ Unclear Difference Between Leakage and Designed Release
Some projects require controlled release, while others require strong retention until intracellular delivery. We help distinguish unwanted leakage from intended release behavior by comparing test conditions, time points, particle integrity, and payload-specific quantification.
BOC Sciences provides retention testing, free payload analysis, particle characterization, and formulation interpretation to help researchers identify leakage mechanisms and improve LNP robustness.
We review payload type, detection method, initial loading data, lipid composition, purification history, storage condition, downstream use, and suspected leakage point to define a practical retention testing strategy.
Test conditions may include dilution, buffer exchange, media incubation, storage, freeze-thaw, filtration, concentration, or comparative handling workflows. Time points and sample volumes are selected according to payload stability and analytical feasibility.
We measure total payload, free payload, retained payload, and sample recovery using payload-compatible separation and quantification methods, with intact-particle and disrupted-particle measurements when applicable.
Retention results are interpreted together with particle size, PDI, zeta potential, visible sample behavior, and formulation conditions. We provide comparative findings that support formulation selection or additional optimization.
Challenge: A research team developing an mRNA-loaded LNP observed acceptable initial encapsulation above 85% after formulation, with particles around 95-130 nm and PDI below 0.22. However, after 10-fold dilution into serum-containing assay medium, the client observed reduced reporter signal and inconsistent uptake-associated fluorescence in in vitro cell models. The team suspected that part of the mRNA became accessible or leaked before cellular delivery evaluation.
Diagnosis: BOC Sciences designed a retention study comparing the original buffer, low-ionic-strength buffer, and serum-containing medium at three dilution ratios. Intact-particle and disrupted-particle RNA measurements showed that the free or accessible RNA fraction increased sharply after dilution into protein-rich medium. DLS analysis also showed a moderate PDI increase, suggesting that dilution changed particle-payload association and reduced colloidal uniformity. The leakage pattern was stronger in the formulation with lower PEG-lipid content and higher residual free lipid signal.
Solution: We screened four formulation variants with adjusted ionizable lipid ratio, helper lipid composition, PEG-lipid level, and post-formulation buffer conditions. Retention testing was repeated after buffer exchange and 10-fold dilution into assay medium. Conditions that improved retention but caused particle growth above 180 nm were excluded. The final candidate balanced retained RNA fraction, particle size, PDI, and sample recovery.
Result: The selected formulation maintained more than 78% retained RNA after dilution challenge, compared with approximately 52-58% for the starting formulation under the same test condition. Particle size remained around 100-125 nm, PDI stayed below 0.23, and the accessible RNA signal was reduced by approximately 45%. The client obtained a more interpretable LNP sample set for downstream in vitro comparison.
Challenge: A biotechnology client working with a 42 kDa recombinant protein payload achieved apparent protein loading of approximately 70% before purification. After centrifugal filtration and buffer exchange, the measured retained protein dropped below 40%, and visible sample turbidity appeared in several batches. The client needed to determine whether the issue was poor encapsulation, purification-induced stripping, or protein aggregation.
Diagnosis: BOC Sciences compared three separation workflows: centrifugal filtration, dialysis, and size-based cleanup under a milder buffer condition. Protein quantification before and after LNP disruption showed that the original centrifugal filtration step removed not only free protein but also weakly associated protein. Particle analysis revealed increased PDI and size drift in concentrated samples, indicating that purification stress contributed to both payload loss and particle instability.
Solution: Our team screened two lipid-to-protein ratios, two PEG-lipid levels, and two buffer systems, then repeated retention testing after the three purification workflows. We also monitored protein recovery, particle size, PDI, zeta potential, and retained fluorescence signal. Conditions with high retained protein but unstable particle size were rejected. A gentler size-based cleanup workflow combined with a moderate PEG-lipid increase produced the best balance between free protein reduction and retained payload.
Result: The optimized condition retained approximately 66-72% of the protein payload after purification, reduced free protein signal by more than 55%, and maintained particle size around 90-115 nm with PDI below 0.21. The client identified purification-induced stripping as the main failure mode and received a practical workflow for preparing cleaner protein LNP samples for functional research.
Experienced LNP Specialist TeamOur scientists have hands-on experience in LNP formulation, encapsulation analysis, leakage evaluation, and payload-specific assay design. We understand how lipid composition, payload chemistry, buffer conditions, and processing steps influence retention behavior.
Advanced Analytical Instrument PlatformsBOC Sciences integrates DLS, zeta potential analysis, fluorescence detection, chromatographic separation, electrophoretic analysis, and payload-specific quantification tools to evaluate retained payload, free payload, particle stability, and formulation changes under defined test conditions.
Professional Method Development CapabilityWe select and optimize testing methods according to payload type, signal sensitivity, particle compatibility, and expected leakage mechanism. This helps reduce assay bias and provides more reliable interpretation for RNA, DNA, protein, peptide, and small-molecule LNP systems.
Efficient Project Execution and ReportingOur structured workflow supports efficient sample review, test design, analytical execution, data comparison, and report preparation. Clients receive clear retention results, particle attribute data, and formulation-relevant conclusions for faster research decision-making.
Flexible Support for Complex LNP ProjectsWe support single-payload, multi-payload, fluorescent, macromolecular, hydrophilic, hydrophobic, and surface-modified LNP systems. Testing plans can be adapted for formulation screening, storage comparison, dilution challenge, freeze-thaw evaluation, or release-related retention studies.
LNP payload retention testing helps determine whether the encapsulated material remains associated with the nanoparticle after preparation, purification, buffer exchange, dilution, storage, or assay-related incubation. A high initial encapsulation efficiency does not always mean that the formulation is stable, because some payloads may gradually leak, detach from the particle surface, or become redistributed after processing. For mRNA, siRNA, proteins, peptides, small molecules, or complex payloads, poor retention can lead to misleading delivery, uptake, release, or functional results. Retention testing therefore provides a more realistic view of formulation robustness and helps researchers distinguish truly retained payload from loosely associated or externally adsorbed material.
LNP payload leakage may be indicated by an increase in free payload signal after dilution, buffer exchange, incubation, or short-term storage. Other warning signs include reduced total payload recovery, particle size drift, broader PDI, obvious zeta potential change, increased aggregation, or functional results that do not match the expected payload input. For protein-loaded LNPs, leakage or instability may also appear as reduced enzymatic activity, weakened fluorescence signal, altered binding response, or increased protein aggregation. BOC Sciences can combine payload quantification, free payload assessment, particle characterization, and function-related readouts when appropriate, helping researchers avoid overinterpreting a single measurement and obtain a clearer view of LNP formulation stability.
LNP retention testing is usually designed around the expected downstream use of the formulation. Common test conditions may include buffer exchange, low- or high-fold dilution, different pH environments, ionic strength variation, short-term storage, freeze-thaw comparison, centrifugal filtration, dialysis, and incubation in assay-relevant media. For protein LNPs, the study may also consider conformational sensitivity, adsorption loss, aggregation risk, and retained functional signal. For nucleic acid LNPs, the focus is often on free nucleic acid release and particle integrity. A well-designed retention study does not simply add more stress conditions; it identifies the conditions most likely to affect payload stability and interpretation in the client’s intended research workflow.
Free payload and LNP-encapsulated payload are commonly differentiated by combining a suitable separation method with quantitative analysis before and after particle disruption. Depending on the payload and formulation, approaches may include dialysis, ultrafiltration, size-exclusion-based separation, centrifugation, chromatography-related workflows, or other payload-compatible methods. The free or externally accessible payload is measured first, and the total payload is then determined after disrupting the LNP structure. For protein payloads, distinguishing surface-adsorbed protein from internally retained protein is especially important because both may contribute to total protein signal. BOC Sciences can select suitable fluorometric, colorimetric, chromatographic, electrophoretic, or activity-related methods according to payload type and project objective.
LNP retention data can directly guide the next round of formulation improvement. If payload leakage increases after dilution, the lipid composition, cholesterol content, PEG-lipid level, charged lipid ratio, or payload-to-lipid ratio may need adjustment. If substantial payload loss occurs during purification or buffer exchange, the separation method, buffer composition, concentration step, or handling conditions may require optimization. If retention appears acceptable but particle size or PDI increases, the mixing conditions, flow rate ratio, lipid concentration, and nanoparticle formation window should be reassessed. By interpreting retention rate, free payload, particle size, PDI, zeta potential, recovery, and functional signal together, researchers can identify more stable and interpretable LNP candidates for downstream studies.
